{"id":395,"date":"2023-07-14T17:45:47","date_gmt":"2023-07-14T17:45:47","guid":{"rendered":"https:\/\/www.snijderlab.org\/news\/?p=395"},"modified":"2024-09-26T13:06:48","modified_gmt":"2024-09-26T13:06:48","slug":"2nd-successful-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.snijderlab.org\/news\/2023\/07\/14\/2nd-successful-clinical-trial\/","title":{"rendered":"2nd Successful clinical trial"},"content":{"rendered":"\n<p>Amazingly, together with the team of <a rel=\"noreferrer noopener\" href=\"http:\/\/www.onkologie.insel.ch\/de\/ueber-uns\/details\/person\/detail\/thomas-pabst\" data-type=\"URL\" data-id=\"http:\/\/www.onkologie.insel.ch\/de\/ueber-uns\/details\/person\/detail\/thomas-pabst\" target=\"_blank\">Prof. Dr. Thomas Pabst<\/a> at the <a rel=\"noreferrer noopener\" href=\"https:\/\/www.insel.ch\/\" data-type=\"URL\" data-id=\"https:\/\/www.insel.ch\/\" target=\"_blank\">Inselspital Bern<\/a>, we have <em>successfully <\/em>completed our second prospective interventional trial!<\/p>\n\n\n\n<p>In the <a href=\"https:\/\/haematologica.org\/article\/view\/haematol.2023.283224\" data-type=\"URL\" data-id=\"https:\/\/haematologica.org\/article\/view\/haematol.2023.283224\" target=\"_blank\" rel=\"noreferrer noopener\">DARTT-1 study<\/a> (<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05732688\" data-type=\"URL\" data-id=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05732688\" target=\"_blank\" rel=\"noreferrer noopener\">NCT05732688<\/a>), patients suffering from Acute Myeloid Leukemia (AML) that had exhausted all registered treatment options received pharmacoscopy guided treatment. Strikingly, patients receiving high-scoring treatments lived three times longer (&gt;3x OS) than patients receiving low-scoring treatments. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-style-default\"><a href=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image.png\"><img loading=\"lazy\" decoding=\"async\" width=\"2673\" height=\"867\" src=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image.png\" alt=\"\" class=\"wp-image-397\" srcset=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image.png 2673w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image-300x97.png 300w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image-1024x332.png 1024w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image-768x249.png 768w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image-1536x498.png 1536w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2024\/01\/image-2048x664.png 2048w\" sizes=\"auto, (max-width: 2673px) 100vw, 2673px\" \/><\/a><\/figure>\n\n\n\n<p>The study results are published open access in <a href=\"https:\/\/haematologica.org\/article\/view\/haematol.2023.283224\" data-type=\"URL\" data-id=\"https:\/\/haematologica.org\/article\/view\/haematol.2023.283224\">Haematologica<\/a>. Efforts in the lab were led by teamwork between <a href=\"https:\/\/www.linkedin.com\/in\/yannik-severin\/\" data-type=\"URL\" data-id=\"https:\/\/www.linkedin.com\/in\/yannik-severin\/\" target=\"_blank\" rel=\"noreferrer noopener\">Yannik Severin<\/a>, <a href=\"https:\/\/www.linkedin.com\/in\/yasmin-festl\/\" data-type=\"URL\" data-id=\"https:\/\/www.linkedin.com\/in\/yasmin-festl\/\" target=\"_blank\" rel=\"noreferrer noopener\">Yasmin Festl<\/a>, and at the Inselspital by <a href=\"https:\/\/www.linkedin.com\/in\/jonas-andreas-schmid\/\" data-type=\"URL\" data-id=\"https:\/\/www.linkedin.com\/in\/jonas-andreas-schmid\/\" target=\"_blank\" rel=\"noreferrer noopener\">Jonas Schmid<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amazingly, together with the team of Prof. Dr. Thomas Pabst at the Inselspital Bern, we have successfully completed our second prospective interventional trial! In the DARTT-1 study (NCT05732688), patients suffering from Acute Myeloid Leukemia (AML) that had exhausted all registered treatment options received pharmacoscopy guided treatment. Strikingly, patients receiving high-scoring treatments lived three times longer&hellip; <a class=\"more-link\" href=\"https:\/\/www.snijderlab.org\/news\/2023\/07\/14\/2nd-successful-clinical-trial\/\">Continue reading <span class=\"screen-reader-text\">2nd Successful clinical trial<\/span> <span class=\"meta-nav\" aria-hidden=\"true\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,5],"tags":[],"class_list":["post-395","post","type-post","status-publish","format-standard","hentry","category-news","category-publications"],"_links":{"self":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/comments?post=395"}],"version-history":[{"count":6,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/395\/revisions"}],"predecessor-version":[{"id":416,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/395\/revisions\/416"}],"wp:attachment":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/media?parent=395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/categories?post=395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/tags?post=395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}